46M-12269-59278
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 900 / CA
- Registered
- 2022-06-20
- Relationship
- Child or adolescent in my care
- Guardian
- 5ET-20245-26776
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-20
Registered in v-safe
-
2022-09-07
Dose 1 — Moderna
- 2022-09-08
- 2022-09-09
- 2022-09-10
- 2022-09-11
- 2022-09-12
- 2022-09-13
- 2022-09-14
- 2022-09-21
- 2022-09-28
-
2022-10-05
Dose 2 — ModernaCo-administered: Flu
- 2022-10-05
-
2022-10-06
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Constipation — Feeling: Good · FeverFree text: Possibly dehydrated and constipatedMedDRA releases: 2024-11 · check-in free text available
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
-
2022-10-21
Survey response — day 14, dose 2, under 3MedDRA: Nasopharyngitis, Pyrexia, Rhinorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Common cold symptoms of runny nose and feverMedDRA releases: 2024-11 · check-in free text available
-
2022-10-21
Report sent to call center — day 14, dose 2, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-24
- 2022-10-26
- 2022-11-02
- 2022-11-09
-
2022-11-16
Survey response — day 42, dose 2, under 3MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend schoolFree text: Upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-30
Dose 3 — Moderna
- 2023-01-04
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-07 | Moderna | No |
| 2 | 2022-10-05 | Moderna | Flu |
| 3 | 2022-12-30 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-21 | Unsuccessful |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Possibly dehydrated and constipated
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Common cold symptoms of runny nose and fever
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Upper respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Constipation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release